In this study, we investigated whether the blockade of the PD-1/B7H1 immune checkpoint can enhance the activated mouse NK cell-mediated killing of mouse glioma stem-like cells (GL261GSCs) isolated from the GL261 cell line in in vitro experiments. The gene discussed is PDCD1; the disease is central nervous system cancer.